These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36394450)

  • 1. Impact of adjuvant therapy on outcomes after curative-intent resection for distal cholangiocarcinoma.
    Hou JJ; Maithel SK; Weber SM; Poultsides G; Wolfgang CL; Fields RC; He J; Scoggins C; Idrees K; Shen P; Zhang XF; Pawlik TM
    J Surg Oncol; 2023 Mar; 127(4):607-615. PubMed ID: 36394450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.
    Zhang XF; Xue F; Dong DH; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    Ann Surg; 2021 Dec; 274(6):e1187-e1195. PubMed ID: 31972643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph Node Examination and Patterns of Nodal Metastasis Among Patients with Left- Versus Right-Sided Intrahepatic Cholangiocarcinoma After Major Curative-Intent Resection.
    Zhang XF; Xue F; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Cauchy F; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    Ann Surg Oncol; 2023 Mar; 30(3):1424-1433. PubMed ID: 36400889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.
    Fisher SB; Patel SH; Kooby DA; Weber S; Bloomston M; Cho C; Hatzaras I; Schmidt C; Winslow E; Staley CA; Maithel SK
    HPB (Oxford); 2012 Aug; 14(8):514-22. PubMed ID: 22762399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas.
    Nakanishi Y; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Matsui A; Tanaka K; Murakami S; Ebihara Y; Kurashima Y; Narasaki H; Amano T; Shichinohe T; Hirano S
    Ann Surg Oncol; 2020 Oct; 27(11):4171-4180. PubMed ID: 32363510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.
    Yamamoto Y; Sugiura T; Todaka A; Okamura Y; Ito T; Ashida R; Kakuda Y; Nakanuma Y; Uesaka K
    World J Surg; 2018 Oct; 42(10):3331-3340. PubMed ID: 29619514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.
    Lopez-Aguiar AG; Ethun CG; Pawlik TM; Tran T; Poultsides GA; Isom CA; Idrees K; Krasnick BA; Fields RC; Salem A; Weber SM; Martin RCG; Scoggins CR; Shen P; Mogal HD; Beal EW; Schmidt C; Shenoy R; Hatzaras I; Maithel SK
    Ann Surg Oncol; 2019 Jun; 26(6):1814-1823. PubMed ID: 30877497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study.
    Wei T; Zhang XF; He J; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    Br J Surg; 2022 Jun; 109(7):610-616. PubMed ID: 35511599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spread of lymph node metastasis and adjuvant therapy for distal cholangiocarcinoma.
    Kurahara H; Mataki Y; Idichi T; Kawasaki Y; Mori S; Sasaki K; Arigami T; Nakajo A; Fukukura Y; Higashi M; Ohtsuka T
    Int J Clin Oncol; 2022 Jul; 27(7):1212-1221. PubMed ID: 35543887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
    Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implication of tumor site in terms of node metastasis for intrahepatic cholangiocarcinoma.
    Lee W; Jeong CY; Jang JY; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Ryu JH; Yang K; Choi CS; Park YH; Nah YW; Kim R; Navarro J; Han DH; Choi GH; Kang CM; Kim KS; Hong SC
    Eur J Surg Oncol; 2020 May; 46(5):832-838. PubMed ID: 31806519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion.
    Kim HJ; Kim CY; Hur YH; Koh YS; Kim JC; Kim HJ; Cho CK
    Surg Today; 2014 Oct; 44(10):1879-86. PubMed ID: 24535697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
    Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
    Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
    Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.